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Abstract Expression of prothymosin a, an acidic nuclear pro-
tein implicated in cellular proliferation, has been reported to be 
regulated by c-myc in vitro. We have studied the correlation of 
expression levels between prothymosin a and c-myc, using three 
different in vivo systems, viz. normal ontogenic process of placen-
tal development, lytic viral infection and heat shock treatment. 
The two genes have been found to share a similar expression 
pattern, although prothymosin a mRNA remains always detecta-
ble, indicating the existence of yet another mechanism, in addition 
to c-myc, which regulates its expression in vivo. 
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1. Introduction 
Prothymosin a (ProTa) is a small, 12.S-kDa. highly acidic 
(pI 3.S) protein [I) localized in the nucleus [2-4). The isolation 
of ProT a from a number of vertebrate species [1,S-7). its wide 
tissue distribution [6-9) and its high evolutionary conservation 
[10-11) indicate an important role for the protein in the cell. 
Although this role remains to be elucidated. accumulated eVI-
dence supports a function related to proliferation events. For 
example. ProT a gene expression was found to be elevated in 
proliferating relative to quiescent cells [12-14) and ProTa anti-
sense oligomers were able to inhibit cell division in myeloma 
cells [IS). Moreover, ProT a levels were reported to be elevated 
in malignant cells and tissues compared with healthy ones. 
indicating its possible participation in the tumongenic process 
[16-18). 
The view that ProT a is mvolved in proliferatIOn is strongly 
supported by the finding that activation of c-myc directly in-
duces transcnption of the ProT a gene in vitro [19). This induc-
tion was reported to be due to the consensus binding site for 
c-myc (E box) that exists in the first intron of the ProTa gene 
[20). It is well-established that c-myc IS the most prominent 
nuclear oncogene and its implication in the control of cellular 
proliferation possibly involves the induction of ProT a [19-21). 
To investigate the correlation between ProTa and c-myc we 
studied the expression of the two genes during normal onto-
genic process, viral infection and heat shock treatment. In all 
systems, ProTa gene expression variations coincided in time 
with those of c-myc. but ProTa mRNA could be detected even 
after c-myc had ceased to be expressed. This pattern of expres-
sIOn under physiological conditions. as well as under stress 
conditIOns. mdicates that the oncogene could influence ProTa 
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gene expression in vivo but also suggests multiple levels of 
regulation for ProTa. 
2. Materials and methods 
2.1 Cell cllltllre. Viral injection and thermal treatment 
F9. CVI and HeLa cells were grown as monolayer In Oulbecco's 
modified Eagle's medIUm. OMEM, supplemented with 10% fetal calf 
serum (FCS). Oaudl cells were cultured In suspension in Roswell Park 
Memorial Institute medIUm, RPMI 1640. supplemented With 20% FCS. 
F9 cells were Induced to differentiate with retinolc acid (10-') and 
dibutyryl c-AMP (10-') as descnbed [22]. Viral infections were carried 
out With adenmlrus type 5 at a multiplicity of 50 pfulcell in OM EM 
without serum. After 90 min of virus absorptlon, the cells were fed With 
complete medIUm and allowed to grow. Thermal treatment was per-
formed by plaCing the cells In a water bath set at 42.5°C for the 
indicated tlme pOints. while the control cells remained at 37°C 
2] RNA Isolation. Northern analrsl!, and dot-blot analrsls 
Total RNA was extracted by the aCid guanidiniumJphenol/chloro-
form method as descnbed by Chomczynskt and Sacchi [23] For North-
ern analysis, ahquots of 15 fig RNA were fractIOnated on 08% agarose-
2.2 M formaldehyde gels and transferred overmght to nylon membrane 
(Hybond N, Amersham). For dot-blot analYSIS, IS or 30 fig RNA wa, 
immobilized on nylon membrane [9]. Prehybndization, hybridization 
and washes were carned out as described [9]. The c-ONA probes em-
ployed for detection were a 1200-bp EcoRI-EcoRI fragment for ProTa 
[10]. a 400-bp P.ltI-PstI fragment for c-myc second exon. a 1460-bp 
EcoRI-Sad fragment for E IA. and a 2460-bp EcoRI-EcoRI fragment 
for heat-shock protein 70 (Hsp 70), labeled with e'p]dCTP by random 
pnming [24]. 
3. Results and discussion 
Since c-myc is known to influence cellular proliferation proc-
esses [19,21). the possibility exists that the involvement of 
ProTa in proliferation may be related to the induction of the 
ProTa gene by c-myc [19]. To test this hypothesis. we examined 
ProTa expression under conditions that are known to influence 
c-myc expression. ProTa and c-myc gene expression were illl-
tially analysed during placental development The levels of each 
mRNA at different developmental stages were determined by 
dot-blot analysis. In developing placenta, the highest levels of 
ProTa mRNA were detected at S weeks, while high levels were 
also detectable at 6 weeks of gestation (Fig. I, upper panel). 
Considerable decrease was observed in 8 weeks. while in full-
term placenta ProTa mRNA levels were very low, but still 
detectable (Fig. 1. upper panel). Expression of c-myc mRNA 
was also high at 6 weeks but undetectable in full-term placenta 
(Fig. I, lower panel). in agreement With reported data that 
relate the appearance of c-myc to the proliferation activity of 
the tissue [2S). Our findings thus establish a parallel between 
the expression of the two genes in normal tissue development 
and strengthen reports supporting a similar correlatIOn III the 
case of colon cancers [18). 
The fact that proliferative events are often inversely corre-
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Fig. 1. Upper panel: dot-blot analysIs of 15 j1g total RNA, prepared 
from developing and full-term placenta at indicated weeks of preg-
nancy, using ProTa eDNA probe Lower panel: dot-blot analysis of 15 
and 30 j1g total RNA prepared from placenta at 6 weeks and full-term 
using c-myc cDNA probe for detectIOn. 
lated with differentiation led us to examme ProTo: mRNA 
levels in rat embryonal carcinoma, F9, cell differentiation. In 
this system, c-myc expression is known to be repressed [26). 
Using Northern analysis we observed a significant decrease in 
ProTa mRNA levels in terminally differentiated F9 cells com-
pared to the undifferentiated control cells (Fig. 2). It should be 
noted that lower levels of ProTa and c-myc mRNA have also 
been detected in human myeloid leukemic HL-60 differentiated 
cells [27-28). Therefore. it seems likely that the link between 
Hours post-infection 
M 1 3 5 7 10 12 22 29 
c-myc 
E1A 
Fig. 3. HeLa cells were infected with adenovirus type 5 and total RNA 
was prepared at the indicated times post-mfection. Total RNA was also 
prepared from mock infected cells (lane M). Equal amounts of RNA 
(15 j1g) were analysed by Northern blottmg utilizing the ProTa and 
c-myc cDNAs as probes. The same samples were hybridized to an 
EcoRI-SacI fragment for the EIA region of adenovirus to monitor the 
progressIOn of viral mfection. 
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Fig. 2 Equal amounts of total RNA (15 j1g) prepared from F9 cells 
(lane I), differentiated F9 cells (lane 2) and differentiated F9 cells 
infected with adenovirus type 5 (lane 3). were separed on an agarose-
formaldehyde gel, blotted to nylon membrane and hybridized with 
ProTa eDNA probe 
ProTa expression and differentiation is a consequence of the 
role of the protein in cell proliferation. To test this hypothesis 
we investigated ProTa mRNA expression after viral infection 
of differentiated F9 cells with a DNA tumor virus, since it is 
known that viral infections transmit proliferation signals to the 
otherwise terminally differentiated cells [22]. Using Northern 
analysis we observed that adenoviral infection indeed restores 
ProTa mRNA to the original undifferentiated levels (Fig. 2). 
This result indicates once again that restoration of proliferation 
leads to increased ProTa mRNA expression. 
In an effort to achieve a more detailed study along these lines, 
we examined ProTa and c-myc mRNAs during the course of 
adenoviral infection of He La cells. RNA samples were col-
lected at various time points post-infection and analysed by 
Northern blotting (Fig. 3). The detection of the early region IA 
(EIA) of the virus was used to monitor the progression of viral 
infectIOn. EIA mRNA was detectable at 7 h and its levels were 
further induced as expected during the course of the lytic infec-
tion (Fig. 3). ProTcx mRNA was detected in both infected and 
control cells with a transient increase at 7 h in infected cells, and 
retained elevated levels even after 29 h of infection (Fig. 3). On 
the contrary. c-myc mRNA, which was strongly induced at the 
time point corresponding to the maximum levels of ProTa 
mRNA, i.e. 7 h post-infection, was found to be reduced to 
undetectable levels after 22 h of infection (Fig. 3). In conclu-
sion, our results show that maximum levels of ProT a and c-myc 
mRNA occur at the same time pomt of the lytic cycle, but 
ProTa mRNA continues to be expressed late in infection, wIth 
a modest overall decrease. 
Since viral infection can be viewed as a kind of stress, we 
studied the response of ProTa and c-myc genes to heat shock, 
utilizing two cell lInes of different origin, viz. Daudi human B 
cells and CVI monkey kidney cells. The above cell lines were 
incubated at 37°C (control) or at 42.SoC for various time peri-
ods and the mRNAs for ProTa and c-myc were analysed by 
Northern blotting (FIg. 4). In Daudi cells, the ProTa mRNA 
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Fig. 4. Daudl and CVI cells were heat shock treated at 42.5°C for the indicated lIme periods and total RNA was prepared. In both cases, total RNA 
was also prepared from control cells at zero time (lane C) and 9 h (lane C) of incubatIOn at 37°C Equal amounts of RNA (15 /lg) were analysed 
by Northern blottmg utihzing ProTer, c-myc and Hsp 70 cDNAs as probes. 
accumulation was found to drop gradually after heat shock 
(Fig. 4). A significant decrease was observed after 6 h reaching 
a plateau at 9 h (Fig. 4). A different pattern of expression was 
observed m CVl cells. ProTa mRNA was induced within the 
first 1.5 h, but the reduction observed at 6 h eventually declined 
to control levels (Fig. 4). Although the ProTa expression pat-
tern was different in the two cell lines examined, its correlation 
to c-myc expression was retained. We found that thermal treat-
ment of Daudi cells reduces c-myc mRNA below detection 
(Fig. 4), in agreement with Bukh et al. [29). Similarly, the initial 
increase of c-myc mRNA observed in CV I cells, within the first 
1.5 h of heat treatment, was followed by a sharp reduction 
resulting in undetectable levels as early as 3 h of heat shock 
(Fig. 4). The Hsp 70, examined as a controL was found to be 
induced in both cases within the first 1.5 h as expected (Fig. 4). 
In conclusion, ProTa mRNA is found to be present at vari-
ous levels in all times. Nevertheless, the amount of ProTa 
increases under conditions that induce transcription of c-myc. 
Our results thus establish an apparent correlation between 
ProT a and c-myc mRNA expression during normal tissue de-
velopment, cell differentiation, viral infection and heat shock. 
Our data support the hypothesis that transcription of ProTa 
gene IS a~wciated with that of c-myc and could be under Its 
control. However, our findings utilizing in vivo systems show 
that ProTa is also expressed even in the absence of c-myc 
expression. Therefore, we suggest that, in addition to the c-myc 
transcriptional mduction, ProTa expression is maintained in 
VIVO by additional, although not yet elucidated, regulatory 
mechanisms. 
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